Medicine

Researchers at the Hebrew University enhanced the Elixhauser Comorbidity Model, improving predictions for length of hospital stay, mortality, readmission, and escalated care. The study outperformed the standard Elixhauser model, offering a comprehensive view of patient complexity. These findings benefit healthcare decisions and patient outcomes, with broad implications for the field.

New study suggests that low-level laser therapy (PBM) offers immediate pain relief for Burning Mouth Syndrome (BMS) patients. Over 10 weeks, 30 participants experienced a significant drop in pain scores after each treatment. While efficacy decreased in the following week, a cumulative effect was observed, especially up to the third treatment. The findings highlight the potential of PBM as a promising treatment for BMS, despite some nuances in its effectiveness.

Research introduces new DNA methylation-based method for accurately assessing cell composition in the human pancreas, addressing a critical gap in diabetes research. By overcoming limitations of traditional protein marker-based approaches, the study provides a more precise means to identify specific cell types. The findings offer insights into beta-cell dysfunction across diabetes types and have direct clinical implications, enhancing our understanding of diabetes development and potentially guiding more tailored treatment strategies.

Antibiotic resistance is a growing public health concern with global implications. Antibiotic-resistant infection affects over 2.8 million individuals each year in the United States alone, resulting in more than 35,000 annual deaths. New resistance mechanisms constantly emerge and spread globally, threatening our ability to treat common infectious diseases, such as pneumonia, tuberculosis, and sepsis.

An international team led by Professor Hagai Levine of Hebrew University of Jerusalem’s Hadassah Braun School of Public Health, with Prof. Shanna Swan at the Icahn School of Medicine, Mount Sinai, New York, along with researchers in Denmark, Brazil, Spain, Israel and the USA, published the first meta-analysis to demonstrate declining sperm counts among men from South and Central America, Asia and Africa.

The Hebrew University of Jerusalem (HU) climbed 13 places to rank 77^th among the world’s top universities and number one in Israel, according to the 2022 Academic Ranking of World Universities (ARWU), published today (Monday).  Topping the list were Harvard, followed by Stanford, MIT, Cambridge, and UCLA Berkeley.  Two other Israeli universities placed in the top 100, as well—the Technion and Weizmann Institute both shared the 83^rd spot.  This is a major achievement for Israel’s higher education at large and for Hebrew U., specifically.

With a Constant Renewal of Cell Vitality in Diseased Tissues, This New Drug Will Hopefully Lead to the Treatment or Prevention of Diseases, Such As Alzheimer’s and Parkinson’s

Hebrew University & Hadassah Medical Center Researchers Attribute Discrepancy in Pain Med Prescriptions at Emergency Rooms in US and Israel to Reduced Empathy

The prevalence of dental developmental anomalies (DDA) in survivors of childhood cancer differ according to the type of cancer treatment administered, according to researchers at the Hebrew University (HU)-Hadassah School of Dental Medicine.

Hebrew University Study of 380,000 Births in Israel—a Country with the Highest Fertility Rate among OECD Countries and High Air Pollution Levels—Reveals Troubling Link  

"Within a decade, we hope to increase fertility among older women using anti-viral drugs"—Hebrew University’s Dr. Michael Klutstein.

Throughout much of the world, increasing numbers of women are delaying having their first child until they are in their late thirties, and even into their forties.  At this age, their eggs are rapidly deteriorating and, even with IVF, their prospects of conception are far from guaranteed.